Emergent cardiovascular risk factors in the very elderly

References

• Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin. Geriatr. Med. 25(4), 563–577, vii (2009).
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Coull AJ, Silver LE et al.; Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366(9499), 1773–1783 (2005).
   PubMed Web of Science ®Google Scholar
• Roger VL, Weston SA, Killian JM et al. Time trends in the prevalence of atherosclerosis: a population-based autopsy study. Am. J. Med. 110(4), 267–273 (2001).
   PubMed Web of Science ®Google Scholar
• van Oostrom O, Velema E, Schoneveld AH et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc. Pathol. 14(3), 126–134 (2005).
   PubMed Web of Science ®Google Scholar
• Terry DF, Evans JC, Pencina MJ et al. Characteristics of Framingham offspring participants with long-lived parents. Arch. Intern. Med. 167(5), 438–444 (2007).
   PubMedGoogle Scholar
• Lewington S, Whitlock G, Clarke R et al.; Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370, 1829–1839 (2007).
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al.; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4), 412–423 (2010).
   PubMed Web of Science ®Google Scholar
• Greenlund LJ, Nair KS. Sarcopenia – consequences, mechanisms, and potential therapies. Mech. Ageing Dev. 124(3), 287–299 (2003).
   PubMed Web of Science ®Google Scholar
• Nair KS. Aging muscle. Am. J. Clin. Nutr. 81(5), 953–963 (2005).
   PubMed Web of Science ®Google Scholar
• Short KR, Bigelow ML, Kahl J et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl Acad. Sci. USA 102(15), 5618–5623 (2005).
   PubMed Web of Science ®Google Scholar
• Marzetti E, Calvani R, Bernabei R, Leeuwenburgh C. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty – a mini-review. Gerontology 58(2), 99–106 (2012).
   PubMed Web of Science ®Google Scholar
• Tan LJ, Liu SL, Lei SF, Papasian CJ, Deng HW. Molecular genetic studies of gene identification for sarcopenia. Hum. Genet. 131(1), 1–31 (2012).
   PubMed Web of Science ®Google Scholar
• Hamrick MW, Herberg S, Arounleut P et al. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem. Biophys. Res. Commun. 400(3), 379–383 (2010).
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Carlson CL, Visser M et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J. Appl. Physiol. 90(6), 2157–2165 (2001).
   PubMed Web of Science ®Google Scholar
• Waters DL, Qualls CR, Dorin RI, Veldhuis JD, Baumgartner RN. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. J. Gerontol. A Biol. Sci. Med. Sci. 63(5), 536–541 (2008).
   PubMed Web of Science ®Google Scholar
• Alexandersen P, Tankó LB, Bagger YZ, Jespersen J, Skouby SO, Christiansen C. Associations between aortic calcification and components of body composition in elderly men. Obesity (Silver Spring). 14(9), 1571–1578 (2006).
   PubMed Web of Science ®Google Scholar
• Ochi M, Kohara K, Tabara Y et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 212(1), 327–332 (2010).
   PubMed Web of Science ®Google Scholar
• O’Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N. Engl. J. Med. 365(22), 2098–2109 (2011).
   PubMed Web of Science ®Google Scholar
• Stepto NK, Coffey VG, Carey AL et al. Global gene expression in skeletal muscle from well-trained strength and endurance athletes. Med. Sci. Sports Exerc. 41(3), 546–565 (2009).
   PubMed Web of Science ®Google Scholar
• Xue QL. The frailty syndrome: definition and natural history. Clin. Geriatr. Med. 27(1), 1–15 (2011).
   PubMed Web of Science ®Google Scholar
• Fedarko NS. The biology of aging and frailty. Clin. Geriatr. Med. 27(1), 27–37 (2011).
   PubMed Web of Science ®Google Scholar
• Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am. J. Cardiol. 103(11), 1616–1621 (2009).
   PubMed Web of Science ®Google Scholar
• Newman AB, Simonsick EM, Naydeck BL et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 295(17), 2018–2026 (2006).
   PubMed Web of Science ®Google Scholar
• Sikora E, Arendt T, Bennett M, Narita M. Impact of cellular senescence signature on ageing research. Ageing Res. Rev. 10(1), 146–152 (2011).
   PubMed Web of Science ®Google Scholar
• Minamino T, Yoshida T, Tateno K et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 108(18), 2264–2269 (2003).
   PubMed Web of Science ®Google Scholar
• Salpea KD, Humphries SE. Telomere length in atherosclerosis and diabetes. Atherosclerosis 209(1), 35–38 (2010).
   PubMed Web of Science ®Google Scholar
• Ogami M, Ikura Y, Ohsawa M et al. Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 24(3), 546–550 (2004).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AL, Kronmal RA, Gardner JP et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol. 165(1), 14–21 (2007).
   PubMed Web of Science ®Google Scholar
• Willeit P, Willeit J, Brandstätter A et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler. Thromb. Vasc. Biol. 30(8), 1649–1656 (2010).
   PubMed Web of Science ®Google Scholar
• Wilson WR, Herbert KE, Mistry Y et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur. Heart J. 29(21), 2689–2694 (2008).
   PubMed Web of Science ®Google Scholar
• Xiao Q, Kiechl S, Patel S et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis – results from a large population-based study. PLoS ONE 2(10), e975 (2007).
   Google Scholar
• Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 106(1), 326–332 (2009).
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr. Opin. Immunol. 21(4), 418–424 (2009).
   PubMed Web of Science ®Google Scholar
• Pawelec G, Derhovanessian E. Role of CMV in immune senescence. Virus Res. 157(2), 175–179 (2011).
   PubMed Web of Science ®Google Scholar
• Kim S, Bi X, Czarny-Ratajczak M et al. Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity. Biogerontology 13(2), 119–131 (2012).
   PubMed Web of Science ®Google Scholar
• Yamashita S, Ogawa K, Ikei T, Udono M, Fujiki T, Katakura Y. SIRT1 prevents replicative senescence of normal human umbilical cord fibroblast through potentiating the transcription of human telomerase reverse transcriptase gene. Biochem. Biophys. Res. Commun. 417(1), 630–634 (2012).
   PubMed Web of Science ®Google Scholar
• Yu J, Auwerx J. The role of sirtuins in the control of metabolic homeostasis. Ann. NY Acad. Sci. 1173(Suppl. 1), E10–E19 (2009).
   PubMed Web of Science ®Google Scholar
• Nisoli E, Tonello C, Cardile A et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310(5746), 314–317 (2005).
   PubMed Web of Science ®Google Scholar
• Stein S, Schäfer N, Breitenstein A et al. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging (Albany. NY). 2(6), 353–360 (2010).
   PubMedGoogle Scholar
• Zhang QJ, Wang Z, Chen HZ et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 80(2), 191–199 (2008).
   PubMed Web of Science ®Google Scholar